StockNews.com began coverage on shares of Streamline Health Solutions (NASDAQ:STRM – Free Report) in a research note published on Saturday morning. The brokerage issued a sell rating on the stock.
Separately, Craig Hallum raised Streamline Health Solutions to a “strong-buy” rating in a research report on Thursday, September 5th.
Streamline Health Solutions Trading Down 0.5 %
Streamline Health Solutions (NASDAQ:STRM – Get Free Report) last released its quarterly earnings results on Monday, December 16th. The company reported ($0.61) earnings per share for the quarter. Streamline Health Solutions had a negative net margin of 92.72% and a negative return on equity of 44.85%.
About Streamline Health Solutions
Streamline Health Solutions, Inc offers health information technology solutions and associated services for hospitals and health systems in the United States and Canada. The company offers RevID, an automated revenue reconciliation software; eValuator, a coding analysis platform; data comparison engine; coding and clinical documentation improvement (CDI) solutions, including CDI, abstracting, and physician query; and financial management solutions, such as accounts receivable management, denials management, claims processing, spend management, and audit management.
Featured Stories
- Five stocks we like better than Streamline Health Solutions
- How to Calculate Options Profits
- 3 Must-Hold Stocks with Double-Digit Upside for 2025
- Most active stocks: Dollar volume vs share volume
- Micron: Why Now Is the Time to Be Brave
- Market Cap Calculator: How to Calculate Market Cap
- 3 Stocks That Wall Street Insiders Can’t Stop Buying
Receive News & Ratings for Streamline Health Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Streamline Health Solutions and related companies with MarketBeat.com's FREE daily email newsletter.